Area of research
Hematology · Genetics
Research interest
Research interests include Acute Myeloid Leukemia Research, Hematopoietic Stem Cell Transplantation, Chronic Myeloid Leukemia Treatments, and Mesenchymal stem cell research.
Oral arsenic plus imatinib versus imatinib solely for newly diagnosed chronic myeloid leukemia: a randomized phase 3 trial with 5-year outcomes
Activation of the <scp>HMGB1</scp>‐<scp>TLR4</scp> pathway impacts the functionality of bone marrow mesenchymal stem cells and disrupts macrophage polarization in immune thrombocytopenia
Preclinical Short-term and Long-term Safety of Human Bone Marrow Mesenchymal Stem Cells
Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial
Loss of PRMT7 reprograms glycine metabolism to selectively eradicate leukemia stem cells in CML
Quercetin induces autophagy-associated death in HL-60 cells through CaMKK&beta;/AMPK/mTOR signal pathway
Co-transplantation of mesenchymal stem cells makes haploidentical HSCT a potential comparable therapy with matched sibling donor HSCT for patients with severe aplastic anemia
Busulfan plus fludarabine as a myeloablative conditioning regimen compared with busulfan plus cyclophosphamide for acute myeloid leukemia in first complete remission undergoing allogeneic hematopoietic stem cell transplantation: a prospective and multicenter study